How much is the Anti-Inflammatory Therapeutics Market market?

The anti-inflammatory therapeutics market market size is estimated to grow at $$ 38.7 bn in 2023. Read More

What is the growth rate of the Anti-Inflammatory Therapeutics Market market?

The growth rate of the anti-inflammatory therapeutics market year-over-year is 6.3%. Read More

Which region held the largest market share in the Anti-Inflammatory Therapeutics Market market?

North America is the region to held the largest market share with 42% growth. Read More

Who are the key players in the Anti-Inflammatory Therapeutics Market market?

AbbVie Inc., Alvogen Iceland ehf, Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Cadila Pharmaceuticals Ltd., Cipla Inc., .... Read More

Which Segment has the largest market share in the Anti-Inflammatory Therapeutics Market market?

Application is the segment that has the largest market share in the market. Read More

Anti-inflammatory Therapeutics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, Canada, China - Size and Forecast 2024-2028

Published: May 2024
Pages: 174
SKU: IRTNTR41324

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

2.2 Market characteristics
- Market characteristics analysis

2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition

3.2 Market segment analysis
- Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Anti-Inflammatory Therapeutics Market 2018 - 2022
- Historic Market Size - Data Table on Global Anti-Inflammatory Therapeutics Market 2018 - 2022 ($ billion)

4.2 Application segment analysis 2018 - 2022
- Historic Market Size - Application Segment 2018 - 2022 ($ billion)

4.3 Drug Class segment analysis 2018 - 2022
- Historic Market Size - Drug Class Segment 2018 - 2022 ($ billion)

4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ billion)

4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028

5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
- Chart on Application - Market share 2023-2028 (%)
- Data Table on Application - Market share 2023-2028 (%)

6.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application

6.3 RA - Market size and forecast 2023-2028
- Chart on RA - Market size and forecast 2023-2028 ($ billion)
- Data Table on RA - Market size and forecast 2023-2028 ($ billion)
- Chart on RA - Year-over-year growth 2023-2028 (%)
- Data Table on RA - Year-over-year growth 2023-2028 (%)

6.4 Psoriasis - Market size and forecast 2023-2028
- Chart on Psoriasis - Market size and forecast 2023-2028 ($ billion)
- Data Table on Psoriasis - Market size and forecast 2023-2028 ($ billion)
- Chart on Psoriasis - Year-over-year growth 2023-2028 (%)
- Data Table on Psoriasis - Year-over-year growth 2023-2028 (%)

6.5 MS - Market size and forecast 2023-2028
- Chart on MS - Market size and forecast 2023-2028 ($ billion)
- Data Table on MS - Market size and forecast 2023-2028 ($ billion)
- Chart on MS - Year-over-year growth 2023-2028 (%)
- Data Table on MS - Year-over-year growth 2023-2028 (%)

6.6 Market opportunity by Application
- Market opportunity by Application ($ billion)
- Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by Drug Class

7.1 Market segments
- Chart on Drug Class - Market share 2023-2028 (%)
- Data Table on Drug Class - Market share 2023-2028 (%)

7.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class

7.3 Anti-inflammatory biologicals - Market size and forecast 2023-2028
- Chart on Anti-inflammatory biologicals - Market size and forecast 2023-2028 ($ billion)
- Data Table on Anti-inflammatory biologicals - Market size and forecast 2023-2028 ($ billion)
- Chart on Anti-inflammatory biologicals - Year-over-year growth 2023-2028 (%)
- Data Table on Anti-inflammatory biologicals - Year-over-year growth 2023-2028 (%)

7.4 Corticosteroids - Market size and forecast 2023-2028
- Chart on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
- Data Table on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
- Chart on Corticosteroids - Year-over-year growth 2023-2028 (%)
- Data Table on Corticosteroids - Year-over-year growth 2023-2028 (%)

7.5 NSAIDs - Market size and forecast 2023-2028
- Chart on NSAIDs - Market size and forecast 2023-2028 ($ billion)
- Data Table on NSAIDs - Market size and forecast 2023-2028 ($ billion)
- Chart on NSAIDs - Year-over-year growth 2023-2028 (%)
- Data Table on NSAIDs - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ billion)
- Data Table on Market opportunity by Drug Class ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ billion)
- Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)

9.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ billion)
- Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.11 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ billion)
- Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview

11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

11.3 Landscape disruption
- Overview on factors of disruption

11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered

12.2 Market positioning of companies
- Matrix on companies position and classification

12.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings

12.4 Alvogen Iceland ehf
- Alvogen Iceland ehf - Overview
- Alvogen Iceland ehf - Product / Service
- Alvogen Iceland ehf - Key offerings

12.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key offerings

12.6 Amneal Pharmaceuticals Inc.
- Amneal Pharmaceuticals Inc. - Overview
- Amneal Pharmaceuticals Inc. - Business segments
- Amneal Pharmaceuticals Inc. - Key news
- Amneal Pharmaceuticals Inc. - Key offerings
- Amneal Pharmaceuticals Inc. - Segment focus

12.7 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus

12.8 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings

12.9 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key news
- Eli Lilly and Co. - Key offerings

12.10 F. Hoffmann-La Roche Ltd.
- F. Hoffmann-La Roche Ltd. - Overview
- F. Hoffmann-La Roche Ltd. - Product / Service
- F. Hoffmann-La Roche Ltd. - Key offerings

12.11 Ferring BV
- Ferring BV - Overview
- Ferring BV - Product / Service
- Ferring BV - Key offerings

12.12 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus

12.13 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus

12.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus

12.15 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings

12.16 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus

12.17 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus

13 Appendix